Abstract
This study investigates the hepatoprotective effects and the potential therapeutic mechanisms of loach (Misgurnus anguillicaudatus) lyophilized powder (MLP) on dimethylnitrosamine (DMN) induced liver fibrosis in rats. After treatment with MLP (50, 100, 200 mg/kg), alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (Alb), total protein (TP) and hydroxyproline (Hyp) levels were detected, to assess the destruction of hepatocytes and the extent of liver fibrosis. Matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), hyaluronic acid (HA), Laminin (LN), procollagen type-III (PC-III), collagen type-IV (C-IV), and transforming growth factor-β1 (TGF-β1) contents in serum were all tested using ELISA kits. Alpha-smooth muscle actin (α-SMA) and the tissue inhibitor of metalloproteinase-1 (TIMP-1) protein contents and distribution were evaluated using western blot and immunohistochemical analysis. MLP significantly decreased the serum concentrations of ALT, AST, Hyp, HA, LN, PC-III, C-IV, MMP-2, TIMP-1, α-SMA and TGF-β1, while increasing the contents of Alb and MMP-9. No significant changes on TP serum concentrations were observed. These results suggest that MLP has anti-hepatic fibrosis effects and its mechanism may be associated with the attenuation of extracellular matrix (ECM) synthesis, the acceleration of ECM degradation, inhibition of hepatic stellate cells (HSCs) activation and TGF-β1 expression.
Graphical Abstract
Similar content being viewed by others
Abbreviations
- MLP:
-
Loach (Misgurnus anguillicaudatus) lyophilized powder
- DMN:
-
Dimethylnitrosamine
- FZHY:
-
Fuzheng Huayu
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
- Hyp:
-
Hydroxyproline
- Alb:
-
Albumin
- TP:
-
Total protein
- ELISA:
-
Enzyme linked immunosorbent assay
- HA:
-
Hyaluronic acid
- LN:
-
Laminin
- PC-III:
-
Procollagen type III
- C-IV:
-
Collagen type IV
- TGF-β1 :
-
Transforming growth factor-β1
- MMP-2:
-
Metalloproteinase-2
- MMP-9:
-
Matrix metalloproteinase-9
- TIMP-1:
-
Tissue inhibitor of metalloproteinase-1
- α-SMA:
-
Alpha-smooth muscle actin
- ECM:
-
Extracellular matrix
- HSCs:
-
Hepatic stellate cells
- HCV:
-
Hepatitis C virus
- Cpd 861:
-
Compound 861
- C-III:
-
Collagen types III
- C-IV:
-
Collagen types IV
References
Atzori, L., G. Poli, and A. Perra. 2009. Hepatic stellate cell: a star cell in the liver. International Journal of Biochemistry & Cell Biology 41: 1639–1642.
Bataller, R., and D.A. Brenner. 2005. Liver fibrosis. The Journal of clinical investigation 115: 209–218.
Burdick, J.A., and G.D. Prestwich. 2011. Hyaluronic acid hydrogels for biomedical applications. Journal of Advanced Materials 23: 41–56.
Che, X.H., W.Y. Jiang, D.R. Parajuli, Y.Z. Zhao, S.H. Lee, and D.H. Sohn. 2012. Apoptotic effect of propyl gallate in activated rat hepatic stellate cells. Archives of pharmacal research 35: 2205–2210.
Cheng, K., N. Yang, and R.I. Mahato. 2009. TGF-beta1 gene silencing for treating liver fibrosis. Journal of Molecular pharmaceutics 6: 772–779.
Choi, M.K., J.M. Han, H.G. Kim, J.S. Lee, J.S. Lee, J.H. Wang, S.W. Son, H.J. Park, and C.G. Son. 2013. Aqueous extract of Artemisia capillaris exerts hepatoprotective action in alcohol–pyrazole-fed rat model. Journal of Ethnopharmacology 147: 662–670.
Eagleton, M.J., N. Ballard, E. Lynch, S.D. Srivastava, G.R. Upchurch Jr, and J.C. Stanley. 2006. Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation. Journal of Surgical Research 135: 345–351.
El-Lakkany, N.M., O.A. Hammam, W.H. El-Maadawy, A.A. Badawy, A.A. Ain-Shoka, and F.A. Ebeid. 2012. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. Journal of Parasites & vectors 5: 1–14.
Friedman, S.L. 2008. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655–1669.
Hamama, S., M. Gilbert-Sirieix, M.C. Vozenin, and S. Delanian. 2012. Radiation-induced enteropathy: molecular basis of pentoxifylline-vitamin E anti-fibrotic effect involved TGF-beta1 cascade inhibition. Journal of Radiotherapy and Oncology 105: 305–312.
Hofman, K., B. Hall, H. Cleaver, and S. Marshall. 2011. High-throughput quantification of hydroxyproline for determination of collagen. Journal of Analytical Biochemistry 417: 289–291.
Iimura, O., H. Takahashi, T. Yashiro, S. Madoiwa, Y. Sakata, Y. Asano, and E. Kusano. 2004. Effect of ureteral obstruction on matrix metalloproteinase-2 in rat renal cortex. Journal of Clinical and Experimental Nephrology 8: 223–229.
Kim, H.G., J.M. Han, H.W. Lee, J.S. Lee, S.W. Son, M.K. Choi, D.S. Lee, J.H. Wang, and C.G. Son. 2013. CGX, a multiple herbal drug, improves cholestatic liver fibrosis in a bile duct ligation-induced rat model. Journal of Ethnopharmacology 145: 653–662.
Kong, W.D., J.M. Cao, J. Xu, B. Chen, T. Yang, T.T. Xu, G.M. Lu, J. Li, and X.E. Huang. 2012. Impact of low versus conventional doses of chemotherapy during transcatheter arterial chemo-embolization on serum fibrosis indicators and survival of liver cancer patients. Asian Pacific Journal of Cancer Prevention 13: 4757–4761.
Körner, T., J. Kropf, and A.M. Gressner. 1996. Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. Journal of Hepatology 25: 684–688.
Li, H., Y. Hu, N. Li, and Y. Zhou. 2012a. Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses. Asian Pacific Journal of Cancer Prevention 13: 1589–1593.
Li, Y., J. Zhou, K. Huang, Y. Sun, and X. Zeng. 2012b. Purification of a novel angiotensin I-converting enzyme (ACE) inhibitory peptide with an antihypertensive effect from loach (Misgurnus anguillicaudatus). Journal of Agriculture and Food Chemistry 60: 1320–1325.
Lim, S., S.J. Lee, K.W. Nam, K.H. Kim, and W. Mar. 2013. Hepatoprotective effects of reynosin against thioacetamide-induced apoptosis in primary hepatocytes and mouse liver. Archives of pharmacal research 36: 485–494.
Lin, X., S. Zhang, Q. Huang, L. Wei, L. Zheng, Z. Chen, Y. Jiao, J. Huang, S. Fu, and R. Huang. 2012. Protective effect of Fufang-Liu-Yue-Qing, a traditional Chinese herbal formula, on CCl4 induced liver fibrosis in rats. Journal of Ethnopharmacology 142: 548–556.
Liu, C., Y. Hu, L. Xu, C. Liu, and P. Liu. 2009. Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Journal of Chinese Medicine 4: 12.
Liu, C.C., Y.H. Wang, E.Y. Chuang, M.H. Tsai, Y.H. Chuang, C.L. Lin, C.J. Liu, B.Y. Hsiao, S.M. Lin, L.Y. Liu, and M.W. Yu. 2014. Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers. Molecular Carcinogenesis 53: 58–66.
Mak, K.M., L.L. Chen, and T.F. Lee. 2013. Codistribution of collagen type IV and laminin in liver fibrosis of elderly cadavers: immunohistochemical marker of perisinusoidal basement membrane formation. The Anatomical Record 296: 953–964.
Marinho, C.C., T. Bretas, I. Voieta, L.C. Queiroz, R. Ruiz-Guevara, A.L. Teixeira, C.M. Antunes, A. Prata, and J.R. Lambertucci. 2010. Serum hyaluronan and collagen IV as non-invasive markers of liver fibrosis in patients from an endemic area for schistosomiasis mansoni: a field-based study in Brazil. Memórias do INSTITUTO Oswaldo Cruz 105: 471–478.
Miner, J.H., and P.D. Yurchenco. 2004. Laminin functions in tissue morphogenesis. Annual Review of Cell and Developmental Biology 20: 255–284.
Mormone, E., J. George, and N. Nieto. 2011. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Journal of Chemico-Biological Interactions 193: 225–231.
Pan, R.H., F.Y. Xie, H.M. Chen, L.Z. Xu, X.C. Wu, L.L. Xu, and G. Yao. 2011. Salvianolic acid B reverses the epithelial-to-mesenchymal transition of HK-2 cells that is induced by transforming growth factor-beta. Archives of Pharmacal Research 34: 477–483.
Parveen, R., S. Baboota, J. Ali, A. Ahuja, S.S. Vasudev, and S. Ahmad. 2011. Effects of silymarin nanoemulsion against carbon tetrachloride-induced hepatic damage. Archives of Pharmacal Research 34: 767–774.
Pellicoro, A., R.L. Aucott, P. Ramachandran, A.J. Robson, J.A. Fallowfield, V.K. Snowdon, S.N. Hartland, M. Vernon, J.S. Duffield, R.C. Benyon, S.J. Forbes, and J.P. Iredale. 2012. Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Journal of Hepatology 55: 1965–1975.
Peng, J., X. Li, Q. Feng, L. Chen, L. Xu, and Y. Hu. 2013. Anti-fibrotic effect of Cordyceps sinensis polysaccharide: inhibiting HSC activation, TGF-beta1/Smad signalling, MMPs and TIMPs. Journal of Experimental Biology and Medicine 238: 668–677.
Peng, W.H., Y.C. Tien, C.Y. Huang, T.H. Huang, J.C. Liao, C.L. Kuo, and Y.C. Lin. 2010. Fraxinus rhynchophylla ethanol extract attenuates carbon tetrachloride-induced liver fibrosis in rats via down-regulating the expressions of uPA, MMP-2, MMP-9 and TIMP-1. Journal of Ethnopharmacology 127: 606–613.
Pulavendran, S., J. Vignesh, and C. Rose. 2010. Differential anti-inflammatory and anti-fibrotic activity of transplanted mesenchymal vs. hematopoietic stem cells in carbon tetrachloride-induced liver injury in mice. Journal of International immunopharmacology 10: 513–519.
Qi, L., C.Y. Liu, W.Q. Wu, Z.L. Gu, and C.Y. Guo. 2011. Protective effect of flavonoids from Astragalus complanatus on radiation induced damages in mice. Journal of Fitoterapia 82: 383–392.
Qin, C., Y. Ding, K. Huang, and H. Xu. 2008. Protective effect of Misgurnus anguillicaudatus polysaccharide on immunological liver injury in mice. Journal of International Immunopharmacology 8: 607–612.
Qin, C., K. Huang, and H. Xu. 2001. Study on immunonodulating activities of enzymolyzed loach protein. Zhong Yao Cai 24: 879–881.
Rossi, E., L.A. Adams, H.L. Ching, M. Bulsara, G.C. Macquillan, and G.P. Jeffrey. 2013. High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis. Clinical Chemistry and Laboratory Medicine 51: 1107–1114.
Sanyal, A.J., N. Chalasani, K.V. Kowdley, A. Mccullough, A.M. Diehl, N.M. Bass, B.A. Neuschwander-Tetri, J.E. Lavine, J. Tonascia, A. Unalp, M. Van Natta, J. Clark, E.M. Brunt, D.E. Kleiner, J.H. Hoofnagle, and P.R. Robuck. 2010. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. Journal of New England Journal of Medicine 362: 1675–1685.
Shin, D.S., K.W. Kim, H.Y. Chung, S. Yoon, and J.O. Moon. 2013a. Effect of sinapic acid against carbon tetrachloride-induced acute hepatic injury in rats. Archives of Pharmacal Research 36: 626–633.
Shin, D.S., K.W. Kim, H.Y. Chung, S. Yoon, and J.O. Moon. 2013b. Effect of sinapic acid against dimethylnitrosamine-induced hepatic fibrosis in rats. Archives of Pharmacal Research 36: 608–618.
Stanculet, N., A. Grigoras, O. Predescu, A. Floarea-Strat, C. Luca, C. Manciuc, C. Dorobat, and I.D. Caruntu. 2012. Operational scores in the diagnosis of chronic hepatitis. A semi-quantitative assessment. Romanian Journal Of Morphology And Embryology 53: 81–87.
Starkel, P., and I.A. Leclercq. 2011. Animal models for the study of hepatic fibrosis. Journal of Best practice & research Clinical Gastroenterology 25: 319–333.
Wang, L., J. Wang, B.E. Wang, P.G. Xiao, Y.J. Qiao, and X.H. Tan. 2004. Effects of herbal compound 861 on human hepatic stellate cell proliferation and activation. World Journal of Gastroenterology 10: 2831–2835.
Wang, Y., J. Gao, D. Zhang, J. Zhang, J. Ma, and H. Jiang. 2010. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. Journal of Hepatology 53: 132–144.
Wiercinska, E., H.P. Naber, E. Pardali, G. Van Der Pluijm, H. Van Dam, and P. Ten Dijke. 2011. The TGF-beta/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system. Breast Cancer Research and Treatment 128: 657–666.
Xie, H., Y. Tao, J. Lv, P. Liu, and C. Liu. 2013. Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats. Evidence-based Complementary and Alternative Medicine 1: 1–10.
Yang, F.R., B.W. Fang, and J.S. Lou. 2013. Effects of Fufang Biejia Ruangan pills on hepatic fibrosis in vivo and in vitro. World Journal of Gastroenterology 19: 5326.
Yang, Y., S. Yang, M. Chen, X. Zhang, Y. Zou, and X. Zhang. 2008. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts. Journal of Ethnopharmacology 118: 264–270.
You, L., M. Zhao, R.H. Liu, and J.M. Regenstein. 2011. Antioxidant and antiproliferative activities of loach (Misgurnus anguillicaudatus) peptides prepared by papain digestion. Journal of Agriculture and Food Chemistry 59: 7948–7953.
Zhang, C.X., and K.X. Huang. 2006. Mechanism of apoptosis induced by a polysaccharide, from the loach Misgurnus anguillicaudatus (MAP) in human hepatocellular carcinoma cells. JOURNAL OF Toxicology and Applied Pharmacology 210: 236–245.
Acknowledgments
We are grateful for the financial support from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).
Author information
Authors and Affiliations
Corresponding author
Additional information
Qian Zhang, Meng-Meng Shang were contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhang, Q., Shang, MM., Ling, QF. et al. Hepatoprotective effects of loach (Misgurnus anguillicaudatus) lyophilized powder on dimethylnitrosamine-induced liver fibrosis in rats. Arch. Pharm. Res. 44, 1–12 (2021). https://doi.org/10.1007/s12272-014-0445-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-014-0445-y